Merck & Co (MRK) free cash flow

Free cash flow · fiscal 2025
$12.36B

Merck & Co (MRK) generated free cash flow of $12.36B in fiscal 2025 (the year ended December 31, 2025). That is 31.7% lower than the $18.10B of fiscal 2024. Figures as of 18 Nov 2026, 12:34 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$12.36B
Change on fiscal 2024
−31.7%
Growth, 5 years
+16.2% a year
Growth, 10 years
+0.9% a year
Highest on record
$18.10Bfiscal 2024
Lowest on record
$1.93Bfiscal 2009
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Merck & Co free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow grew at a compound 16.2% a year; over ten years the rate was 0.9% a year. Across the 19 fiscal years on record (2007–2025), the highest was $18.10B in fiscal 2024 and the lowest $1.93B in fiscal 2009.

History · 19 fiscal years

Free cash flow by fiscal year

Merck & Co free cash flow, year by year

Merck & Co (MRK) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$12.36B 31.7% down
2024$18.10B 97.9% up
2023$9.14B 37.8% down
2022$14.71B 69.6% up
2021$8.67B 48.9% up
2020$5.82B 42.2% down
2019$10.07B 21.2% up
2018$8.31B 82.1% up
2017$4.56B 47.9% down
2016$8.76B 22.2% down
2015$11.26B 68.7% up
2014$6.67B 34.0% down
2013$10.11B 25.3% up
2012$8.07B 24.3% down
2011$10.66B 16.6% up
2010$9.14B 373.5% up
2009$1.93B 63.4% down
2008$5.27B 11.9% down
2007$5.99B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Merck & Co and comparable companies
CompanyFree cash flowFiscal year
Johnson & Johnson JNJ$19.31B2025
AbbVie ABBV$17.82B2025
Merck & Co MRK$12.36B2025
UnitedHealth Group UNH$16.08B2025
Novartis NVS$15.24B2025
AstraZeneca AZN$8.67B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MRK

Merck & Co, figure by figure

Merck & Co (MRK) overview: price, valuation and scorecardAll health care companies by market value

Merck & Co free cash flow: questions and answers

What is Merck & Co's free cash flow?

Merck & Co (MRK) generated free cash flow of $12.36B in fiscal 2025 (the year ended December 31, 2025). That is 31.7% lower than the $18.10B of fiscal 2024.

What is the growth rate of Merck & Co's free cash flow?

Over the five fiscal years to 2025 free cash flow grew at a compound 16.2% a year; over ten years the rate was 0.9% a year.

What are the highest and lowest free cash flow figures on record for Merck & Co?

Across the 19 fiscal years on record (2007–2025), the highest was $18.10B in fiscal 2024 and the lowest $1.93B in fiscal 2009.

How is Merck & Co's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Merck & Co it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Merck & Co (MRK) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/MRK/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.